Search research articles
Contact Us
Filters
Showing results (851-860 of 1,036) with videos related to
Page
of 104
Sort By:
Proceedings. Biological Sciences
|
October 27, 2021
Animal lifestyle affects acceptable mass limits for attached tags
Rory P Wilson, Kayleigh A Rose, Richard Gunner, et al.
Cancer Research
|
December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development
Dong Lin, Alexander W Wyatt, Hui Xue, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 14, 1998
Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997
P D Rye, N V Bovin, E V Vlasova, et al.
Nature Communications
|
April 9, 2025
GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau
Diana Acosta Ingram, Emir Turkes, Tae Yeon Kim, et al.
Molecular Cancer Therapeutics
|
January 19, 2012
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target
Colin C Collins, Stanislav V Volik, Anna V Lapuk, et al.
The Journal of Infectious Diseases
|
April 18, 2024
Genomic Analysis and Surveillance of Respiratory Syncytial Virus Using Wastewater-Based Epidemiology
Danielle M Allen, Marina I Reyne, Pearce Allingham, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Replenishing Age-Related Decline of IRAK-M Expression in Retinal Pigment Epithelium Attenuates Outer Retinal Degeneration
Jian Liu, David A Copland, Alison J Clare, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
JAMA Oncology
|
June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial
Erica H Bell, Peixin Zhang, Barbara J Fisher, et al.
Science Translational Medicine
|
June 5, 2024
Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration
Jian Liu, David A Copland, Alison J Clare, et al.
Page
of 104
Search research articles
Search
Showing results (851-860 of 1,036) with videos related to
Sort By:
Page
of 104
Proceedings. Biological Sciences
|
October 27, 2021
Animal lifestyle affects acceptable mass limits for attached tags
Rory P Wilson, Kayleigh A Rose, Richard Gunner, et al.
Cancer Research
|
December 21, 2013
High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development
Dong Lin, Alexander W Wyatt, Hui Xue, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
August 14, 1998
Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, September 19-24, 1997
P D Rye, N V Bovin, E V Vlasova, et al.
Nature Communications
|
April 9, 2025
GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau
Diana Acosta Ingram, Emir Turkes, Tae Yeon Kim, et al.
Molecular Cancer Therapeutics
|
January 19, 2012
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target
Colin C Collins, Stanislav V Volik, Anna V Lapuk, et al.
The Journal of Infectious Diseases
|
April 18, 2024
Genomic Analysis and Surveillance of Respiratory Syncytial Virus Using Wastewater-Based Epidemiology
Danielle M Allen, Marina I Reyne, Pearce Allingham, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
Replenishing Age-Related Decline of IRAK-M Expression in Retinal Pigment Epithelium Attenuates Outer Retinal Degeneration
Jian Liu, David A Copland, Alison J Clare, et al.
JCO Precision Oncology
|
September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma
Jessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.
JAMA Oncology
|
June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial
Erica H Bell, Peixin Zhang, Barbara J Fisher, et al.
Science Translational Medicine
|
June 5, 2024
Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration
Jian Liu, David A Copland, Alison J Clare, et al.
Page
of 104